Steve Pagnotta

Steve Pagnotta currently serves as the Senior Director and Head of Commercial Operations for the Eye Care Division at Viatris, a position held since January 2023 following Viatris' acquisition of Oyster Point Pharma. Pagnotta has extensive experience in commercial operations within the ophthalmics franchise across multiple companies including Oyster Point Pharma, Novartis, Takeda, and Shire. Notable achievements include leading teams to execute effective salesforce strategies and overseeing incentive compensation activities for numerous products. Pagnotta's educational background includes an MBA in Health Sector Management from the Questrom School of Business at Boston University and a BS in Finance and Marketing from Babson College.